These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 11826198

  • 41. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 42. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 43. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
    Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC.
    Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
    [Abstract] [Full Text] [Related]

  • 44. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis.
    Holt S, Suder A, Weatherall M, Cheng S, Shirtcliffe P, Beasley R.
    BMJ; 2001 Aug 04; 323(7307):253-6. PubMed ID: 11485952
    [Abstract] [Full Text] [Related]

  • 45. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
    Clark DJ, Grove A, Cargill RI, Lipworth BJ.
    Thorax; 1996 Mar 04; 51(3):262-6. PubMed ID: 8779128
    [Abstract] [Full Text] [Related]

  • 46. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.
    Price JF, Russell G, Hindmarsh PC, Weller P, Heaf DP, Williams J.
    Pediatr Pulmonol; 1997 Sep 04; 24(3):178-86. PubMed ID: 9330414
    [Abstract] [Full Text] [Related]

  • 47. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB, Bons J, Legendre M, Prud'Homme A, Bugnas B, Evano-Celli I, Stuart AM.
    Respir Med; 2000 Jun 04; 94 Suppl B():S29-34. PubMed ID: 10919683
    [Abstract] [Full Text] [Related]

  • 48. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E, Van De Velde V, Marissens S, Engelstätter R, Vincken W, Pauwels R.
    Pulm Pharmacol Ther; 2005 Jun 04; 18(5):328-36. PubMed ID: 15939311
    [Abstract] [Full Text] [Related]

  • 49. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.
    Fabbri L, Burge PS, Croonenborgh L, Warlies F, Weeke B, Ciaccia A, Parker C.
    Thorax; 1993 Aug 04; 48(8):817-23. PubMed ID: 8211872
    [Abstract] [Full Text] [Related]

  • 50. Inhaled corticosteroid therapy reduces the early morning peak in cortisol and aldosterone.
    Wilson AM, Sims EJ, Struthers AD, Lipworth BJ.
    Clin Sci (Lond); 1998 Oct 04; 95(4):513-7. PubMed ID: 9748428
    [Abstract] [Full Text] [Related]

  • 51. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
    Can Respir J; 1999 Oct 04; 6(1):45-51. PubMed ID: 10202220
    [Abstract] [Full Text] [Related]

  • 52. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
    Szefler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D.
    Chest; 2005 Sep 04; 128(3):1104-14. PubMed ID: 16162694
    [Abstract] [Full Text] [Related]

  • 53. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
    Sheth KK, Cook CK, Philpot EE, Prillaman BA, Witham LA, Faris MA, Klein KC, Rickard KA.
    Allergy Asthma Proc; 2004 Sep 04; 25(2):115-20. PubMed ID: 15176496
    [Abstract] [Full Text] [Related]

  • 54. Systematic review of the dose-response relation of inhaled fluticasone propionate.
    Masoli M, Weatherall M, Holt S, Beasley R.
    Arch Dis Child; 2004 Oct 04; 89(10):902-7. PubMed ID: 15383431
    [Abstract] [Full Text] [Related]

  • 55. Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma.
    White M, Crisalida T, Li H, Economides A, Kaliner M.
    Ann Allergy Asthma Immunol; 2006 Mar 04; 96(3):437-44. PubMed ID: 16597078
    [Abstract] [Full Text] [Related]

  • 56. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
    Falcoz C, Horton J, Mackie AE, Harding SM, Daley-Yates PT.
    Clin Pharmacokinet; 2000 Mar 04; 39 Suppl 1():31-7. PubMed ID: 11140431
    [Abstract] [Full Text] [Related]

  • 57. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP, Lundback B, Yigla M, Sykes AP.
    Respir Med; 2000 Jun 04; 94 Suppl B():S35-41. PubMed ID: 10919684
    [Abstract] [Full Text] [Related]

  • 58. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
    Am J Respir Crit Care Med; 1999 Jul 04; 160(1):157-61. PubMed ID: 10390394
    [Abstract] [Full Text] [Related]

  • 59. Evaluation of adrenocortical function in 3-7 aged asthmatic children treated with moderate doses of fluticasone propionate: reliability of dehydroepiandrosterone sulphate (dhea-s) as a screening test.
    Sahiner UM, Cetinkaya S, Ozmen S, Arslan Z.
    Allergol Immunopathol (Madr); 2011 Jul 04; 39(3):154-8. PubMed ID: 21257254
    [Abstract] [Full Text] [Related]

  • 60. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
    Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M.
    Pol Merkur Lekarski; 2004 Jul 04; 17 Suppl 2():11-8. PubMed ID: 15688664
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.